Weight-loss products that promise consumers quick and easy ways to shed pounds don't live up to their claims and, even worse, can cause serious harm, FDA has announced.
Weight-loss products that promise consumers quick and easy ways to shed pounds don't live up to their claims and, even worse, can cause serious harm, FDA has announced.
Federal regulators found that 69 products claiming to be dietary supplements contained hidden prescription drugs or compounds that have not been adequately studied in humans.
"These products are not legal dietary supplements," said Michael Levy, director of FDA's Division of New Drugs and Labeling Compliance. They are actually very powerful drugs masquerading as 'all-natural' or 'herbal' supplements, and they carry significant risks to unsuspecting consumers. We have even seen deaths associated with these weight-loss products. Make no mistake - they can kill you."
Many consumers are purchasing these tainted products from foreign sources through the internet; however, some are found on store shelves. Among the undeclared active ingredients FDA discovered in products marketed as dietary supplements are the following:
Potential warning signs
The FDA advises consumers to look for potential warning signs of tainted products. These include:
Dietary supplements, in general, are not FDA-approved, nor do firms need to obtain such approval before marketing their products. Consumers should be aware that dietary supplements sold in stores may not be safe or effective.
FDA widget for pharmacy websites
To keep consumers informed about weight-loss products, FDA is offering pharmacy websites a "Tainted Products Marketed as Supplements” widget. A widget is a portable application that displays featured content directly on a web page. There is no technical maintenance involved and FDA automatically provides content updates to the widget.
For more information on FDA's widget visithttp://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm242603.htm
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.